Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer
Posted on: Tuesday, 7 April 2009, 08:00 CDT
While there is no one, single cause of prostate cancer, there are several factors that appear to increase the risk of developing it, including diet. In the study, researchers from the
The study shows that those men who ate dark, fatty fish one to three times per month had a 36 percent lower risk of prostate cancer as compared to those who had zero dark fish consumption. Furthermore, those who ate dark fish at least once a week had a 57% risk reduction. And, those who consumed little to no Omega-3 EPA/DHA and who also carried the specific COX-2 variant, were five times more likely to develop advanced prostate cancer. However, this association was essentially reversed with increasing consumption of Omega-3 EPA/DHA.
"This study adds to the growing research that shows that regular Omega-3 EPA/DHA consumption by men may lower their risk of developing prostate cancer," said Ocean Nutrition Canada's Vice President, Marketing and Communications,
According to the Canadian Cancer Society, prostate cancer is the most common cancer among Canadian men, with an estimated 24,700 men developing the disease in 2008. In the US, the American Cancer Society's Cancer Facts and Figures 2008 lists prostate cancer as the most diagnosed cancer in American men. The society also ranks prostate cancer as the second most diagnosed and the sixth leading cause of death by cancer among men globally.
In addition to helping lower the risk of developing prostate cancer, Omega-3 EPA/DHA has proven heart health benefits and may reduce the risk of esophageal and colorectal cancer. Additionally, research suggests Omega-3 EPA/DHA may improve cognitive function and symptoms of attention deficit hyperactivity disorder (ADHD), contribute to weight loss, reduce symptoms of depression, and lower the risk of stroke.
About Omega-3:
Omega-3 is an essential fatty acid (EFA), consisting of EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid), and ALA (alpha-linolenic acid). Oily fish, including anchovies, sardines, mackerel, and salmon, are the only known natural sources of Omega-3 EPA/DHA. ALA is found in plants, such as flax and chia. It is important to note that only EPA and DHA contribute to the many health benefits associated with Omega-3. While the body can convert ALA into EPA/DHA, it does so very inefficiently (less than one percent), making it impossible to derive Omega-3-related health benefits from plant sources. Furthermore, although Omega-3 EPA/DHA is vital to overall good health, the human body is not able to produce it on its own, so supplementation is required, either by eating oily fish or foods fortified with Omega-3 EPA/DHA, or by taking fish oil supplements. Learn more about the health benefits of Omega-3 EPA/DHA at www.meg-3.com.
About Ocean Nutrition Canada Limited (ONC):
Ocean Nutrition Canada (ONC) is a privately held company, whose major shareholder is Clearwater Fine Foods Incorporated. Clearwater Fine Foods Incorporated is a diversified holding/investment company whose significant holdings include a controlling interest in Clearwater Seafood's Limited Partnership, the world's largest integrated shellfish harvester and processor.
ONC is a global leading supplier of Omega-3 EPA and DHA ingredients from fish oil...essential nutrients that have been scientifically linked to supporting heart health, brain health, and general wellness. ONC markets its MEG-3(R) ingredients into the Dietary Supplement and Healthy Food markets. To date MEG-3(R) ingredients have been included in over 40 billion servings of food and supplement products world wide. For more information on Ocean Nutrition Canada Limited visit www.ocean-nutrition.com, and for more information on the health benefits of Omega-3 EPA/DHA please visit www.meg-3.com.
SOURCE Ocean Nutrition Canada Ltd.
Source: PR Newswire
Related Articles
- Eating Fatty Fish And Marine Omega-3 Fatty Acids Could Reduce Risk Of Heart Failure
- New Study Reveals Swimming Can Cut Men's Risk of Dying in Half
- Preliminary Data From Human Clinical Trial Shows Vectomega(R), A Revolutionary Omega-3 Phospholipid Complex (DHA/EPA), Has Positive Results in Numerous Areas of Health
- CDC Selects AQS to Continue Providing Allergen and Endotoxin Analyses for National Health and Nutrition Survey
- Czech Minister Calls for Cancer Prevention Campaign to Save Money in Health Care
- Celanese Has Sold Its Omega-3 DHA Business to Lonza
- DHA & EPA, The Lifesaving Omega-3s
- Celanese Reviews Strategic Options for Its Omega-3 DHA Business
- Cancer, Heart Diseases Biggest Killers in Thailand: Health Minister
- Pfizer and New York University School of Medicine Announce the Launch of an Online Men's Sexual Health Referral Network
User Comments (0)

RSS Feeds